Erythropoiesis stimulating agents demonstrate safety and show promise as neuroprotective agents in neonates

Journal of Pediatrics

Volumn 167, Issue 1, 2015, Pages 10-12

  Ohls, Robin K ^a   Christensen, Robert D ^b   Widness, John A ^c   Juul, Sandra E ^d  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPROTECTIVE AGENT; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN; ERYTHROPOIETIN;

APOPTOSIS; BLOOD BRAIN BARRIER; BLOOD DONOR; BRAIN HEMORRHAGE; DRUG BRAIN LEVEL; DRUG SAFETY; EDITORIAL; ERYTHROPOIESIS; GRAY MATTER; HEALTH CARE QUALITY; HEMATOCRIT; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INCIDENCE; INDUCED HYPOTHERMIA; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NEWBORN; NEWBORN INTENSIVE CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; WHITE MATTER INJURY; DEVELOPMENTAL DISABILITIES;

DEVELOPMENTAL DISABILITIES; ERYTHROPOIETIN; HUMANS; INFANT, PREMATURE; NEUROPROTECTIVE AGENTS;

EID: 84937520834     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.03.054     Document Type: Editorial

References (19)

1. S.M. Rhondeau, R.D. Christensen, M.P. Ross, G. Rothstein, and M.A. Simmons Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity." J Pediatr 112 1988 935 940
2. R.K. Ohls, R.D. Christensen, B.D. Kamath-Rayne, A. Rosenberg, S.E. Wiedmeier, M. Roohi, and et al. A randomized, masked, placebo controlled study of darbepoetin administered to preterm infants Pediatrics 132 2013 e119 e127
3. J.C. Fauchere, C. Dame, R. Vonthein, B. Koller, S. Arri, M. Wolf, and et al. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants Pediatrics 122 2008 375 382
4. S.E. Juul, R.J. McPherson, L.A. Bauer, K.J. Ledbetter, C.A. Gleason, and D.E. Mayock A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety Pediatrics 122 2008 383 391
5. Y.W. Wu, L.A. Bauer, R.A. Ballard, D.M. Ferriero, D.V. Glidden, D.E. Mayock, and et al. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics Pediatrics 130 2012 683 691
6. M.C. Baserga, J.C. Beachy, J.K. Roberts, R.M. Ward, R.J. DiGeronimo, W.F. Walsh, and et al. Darbepoetin administration to neonates undergoing cooling for encephalopathy (DANCE): a safety and pharmacokinetic trial Pediatr Res 2015 in press
7. R.K. Ohls, B.D. Kamath-Rayne, R.D. Christensen, S.E. Wiedmeier, A. Rosenberg, J.A. Fuller, and et al. Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin or placebo Pediatrics 133 2014 1023 1030
8. R.M. McAdams, R.J. McPherson, D.E. Mayock, and S.E. Juul Outcomes of extremely low birth weight infants given early high-dose erythropoietin J Perinatol 33 2013 226 230
9. E.E. Rogers, S.L. Bonifacio, H.C. Glass, S.E. Juul, T. Chang, D.E. Mayock, and et al. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy Pediatr Neurol 51 2014 657 662
10. J.C. Fauchere, B. Koller, A. Tschopp, C. Dame, C.M. Ruegger, H.U. Bucher, and et al. Safety of early high-dose recombinant erythropoietin for neuroprotection in very preterm infants J Pediatr 167 2015 52 57
11. R.H. Leuchter, L. Gui, A. Poncet, C. Hagmann, G.A. Lodygensky, E. Martin, and et al. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age JAMA 312 2014 817 824
12. A. Ohlsson, and S.M. Aher Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants Cochrane Database Syst Rev 3 2006 CD004863
13. S. Aher, and A. Ohlsson Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants Cochrane Database Syst Rev 3 2006 CD004868
14. C. Romagnoli, E. Zecca, F. Gallini, P. Girlando, and A.A. Zuppa Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? Eur J Pediatr 159 2000 627 628
15. A. Ohlsson, and S.M. Aher Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants Cochrane Database Syst Rev 4 2014 CD004863
16. S. Aher, and A. Ohlsson Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants Cochrane Database Syst Rev 4 2014 CD004868
17. S. Costa, C. Romagnoli, A.A. Suppa, F. Cota, A. Scorrano, F. Gallini, and et al. How to administer erythropoietin, intravenous or subcutaneous? Acta Paediatr 102 2013 579 583
18. E. Henry, R.D. Christensen, M.J. Sheffield, L.D. Eggert, P.D. Carroll, S.D. Minton, and et al. Why do four NICUs using identical RBC transfusion guidelines have different gestational age-adjusted RBC transfusion rates? J Perinatol 35 2015 132 136
19. R.D. Christensen, P.D. Carroll, and C.D. Josephson Evidence-based advances in transfusion practice in neonatal intensive care units Neonatology 106 2014 245 253